Mechanism of Action: Calcium Channel Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Calcium Channel Antagonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | VERELAN PM | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020943-001 | Nov 25, 1998 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Azurity | VERELAN PM | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020943-002 | Nov 25, 1998 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Azurity | VERELAN PM | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020943-003 | Nov 25, 1998 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Azurity | VERELAN | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 019614-001 | May 29, 1990 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Azurity | VERELAN | verapamil hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 019614-003 | Jan 9, 1992 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
